Polyamines—putrescine, spermidine, spermine, and cadaverine—are small polycationic molecules produced by both the host and the Gut Microbiome. They regulate cell growth, differentiation, apoptosis, and immune function.
In the gut ecosystem, polyamines are metabolic products of amino acid decarboxylation, and their production by specific bacterial communities connects microbial ecology to cardiovascular health, cancer biology, Neuroinflammation, and aging.
Evidence map8 cited passagesInspect provenance +
The arginine-ornithine-putrescine pathway is metabolically connected to nitric oxide synthesis: arginine can be shunted toward either NO (via iNOS) or polyamines (via ODC). This metabolic switch has been observed in neuroinflammation, where EAE (experimental autoimmune encephalomyelitis) drives a shift from NO synthesis to polyamine synthesis, with a massive
Promotes FoxP3+ Treg differentiation.
Mechanism: NF-kB suppression and NO inhibition.
Pro-tumorigenic: High concentrations promote tumor cell proliferation and immune suppression in the tumor microenvironment.
Anti-tumorigenic: Spermidine-modified pullulan reduces the immunosuppressive tumor microenvironment.
Polyamine biosynthesis is enriched in ketogenic diet-fed mice with accelerated ovarian cancer growth.
Ornithine depletion in ASD: Ornithine deficit in autism spectrum disorder may impair polyamine synthesis, contributing to gut barrier dysfunction.
Arginine-NO-polyamine switch: During neuroinflammation, the metabolic switch from arginine to polyamines (rather than NO) may represent a compensatory anti-inflammatory response that could be impaired by chronic metal exposure.
Contents
1. The Major Polyamines2. Microbial Polyamine Production3. Health Effects—The Dual Nature4. Metal Connections5. Open Questions6. Cross-ReferencesThe Major Polyamines#
| Polyamine | Precursor | Key Producers | Primary Functions |
|---|---|---|---|
| Putrescine | Ornithine (via ODC) or arginine (via ADC) | E. coli, Enterococcus, Bacteroides | Cell proliferation; immune modulation; precursor to spermidine |
| Spermidine | Putrescine + decarboxylated SAM | Bacteroides, Fusobacterium, Clostridium | Autophagy induction; cardioprotection; anti-inflammatory |
| Spermine | Spermidine + decarboxylated SAM | Primarily host-derived | Anti-inflammatory; DNA stabilization |
| Cadaverine | Lysine (via LDC) | Enterobacteriaceae, Clostridium | Biofilm formation; acid stress response |
Microbial Polyamine Production#
Gut bacteria produce polyamines through amino acid decarboxylation pathways. Ornithine decarboxylase (ODC): Converts ornithine to putrescine. Widely distributed among Enterobacteriaceae.
Arginine decarboxylase (ADC): Alternative pathway to putrescine via agmatine. Lysine decarboxylase (LDC): Produces cadaverine from lysine. Common in Proteobacteria.
The arginine-ornithine-putrescine pathway is metabolically connected to Nitric Oxide synthesis: arginine can be shunted toward either NO (via iNOS) or polyamines (via ODC).
This metabolic switch has been observed in neuroinflammation, where EAE (experimental autoimmune encephalomyelitis) drives a shift from NO synthesis to polyamine synthesis, with a massive 14-20 fold increase in CSF putrescine.[1]Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosisMarek J. Noga, Adrie Dane, Shanna Shi et al. · 2012Open reference 1 ↓
Health Effects—The Dual Nature#
Cardioprotective Effects#
Bacterially synthesized polyamines, particularly spermidine, have documented cardioprotective effects. Spermidine reduces cardiac hypertrophy and improves echocardiographic parameters Cardiovascular Disease. Spermidine supplementation modifies intestinal microbiota toward anti-inflammatory composition.
Paradoxically, spermidine increases Desulfovibrionaceae while improving cardiovascular outcomes, suggesting context-dependent effects Desulfovibrio.
Anti-Inflammatory and Neuroprotective#
Spermidine is emerging as a promising therapeutic for neuroinflammatory conditions. Promotes FoxP3+ Treg differentiation.[2]Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and TreatmentEduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto · 2022Open reference 2 ↓ Shifts macrophages to M2 (anti-inflammatory) profile.
Inhibits macrophage/T cell migration to spinal cord in EAE models.
Decreases astrocyte and microglia number in neuroinflammation. Mechanism: NF-kB suppression and NO inhibition.[2]Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and TreatmentEduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto · 2022Open reference 2 ↓
Cancer—Context-Dependent#
Polyamines have a dual role in cancer biology. Pro-tumorigenic: High concentrations promote tumor cell proliferation and immune suppression in the tumor microenvironment.[3]Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer MicroenvironmentHanus M, Parada-Venegas D, Landskron G et al. · 2021Open reference 3 ↓ Anti-tumorigenic: Spermidine-modified pullulan reduces the immunosuppressive tumor microenvironment.[3]Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer MicroenvironmentHanus M, Parada-Venegas D, Landskron G et al. · 2021Open reference 3 ↓
Polyamine biosynthesis is enriched in ketogenic diet-fed mice with accelerated ovarian cancer growth.[4]The effects of dietary fat on gut microbial composition and function in a mouse model of ovarian cancerAlHilli MM, Sangwan N, Myers A et al. · 2025Open reference 4 ↓
The dual nature parallels many microbial metabolites: beneficial at physiological concentrations, harmful when Dysbiosis drives overproduction or when the wrong cell types are exposed.
Metal Connections#
Polyamine metabolism intersects with metal biology at several points. Ornithine depletion in ASD: Ornithine deficit in Autism Spectrum Disorder may impair polyamine synthesis, contributing to gut barrier dysfunction.[5]Chang 2024 — Gut Microbiome and Serum Amino Acid Metabolome Alterations in ASDXuening Chang, Yuchen Zhang, Xue Chen et al. · 2024Open reference 5 ↓
Metal cofactors: ODC requires pyridoxal phosphate (vitamin B6), which itself depends on zinc for synthesis. Metal-driven zinc depletion could indirectly impair polyamine production.
Arginine-NO-polyamine switch: During neuroinflammation, the metabolic switch from arginine to polyamines (rather than NO) may represent a compensatory anti-inflammatory response that could be impaired by chronic metal exposure.[1]Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosisMarek J. Noga, Adrie Dane, Shanna Shi et al. · 2012Open reference 1 ↓
Open Questions#
Unresolved questions identified by the current evidence record.
01Can spermidine supplementation reduce neuroinflammation in MS patients, as suggested by EAE models?+
The current WikiBiome record identifies this as an unresolved evidence gap.
02Does metal-driven dysbiosis shift polyamine production toward pro-tumorigenic profiles?+
The current WikiBiome record identifies this as an unresolved evidence gap.
03Is the cardioprotective effect of spermidine mediated through microbiome remodeling or direct cellular effects?+
The current WikiBiome record identifies this as an unresolved evidence gap.
04What is the optimal dietary polyamine intake, and which food sources provide the best profile?+
The current WikiBiome record identifies this as an unresolved evidence gap.
Cross-References#
- Cardiovascular Disease—spermidine cardioprotection
- Colorectal Cancer—polyamine dual role in tumor microenvironment
- microbiome-derived metabolites—broader metabolite framework
- Multiple Sclerosis—spermidine as EAE therapeutic candidate
- Butyrate—co-produced SCFA with synergistic anti-inflammatory effects
- Fermentative Metabolism—amino acid fermentation producing polyamines
- Autism Spectrum Disorder—ornithine deficit impairing polyamine synthesis
References 10
Numbered by first appearance in the article, then reconciled with its declared source list.
- 1
Marek J. Noga, Adrie Dane, Shanna Shi et al. (2012). Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis. Metabolomics.
- 2
Eduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto (2022). Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment. Frontiers in Neuroscience.
- 3
Hanus M, Parada-Venegas D, Landskron G et al. (2021). Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment. Frontiers in Immunology.
- 4
AlHilli MM, Sangwan N, Myers A et al. (2025). The effects of dietary fat on gut microbial composition and function in a mouse model of ovarian cancer. Journal of Ovarian Research.
- 5
Xuening Chang, Yuchen Zhang, Xue Chen et al. (2024). Chang 2024 — Gut Microbiome and Serum Amino Acid Metabolome Alterations in ASD. Nature Scientific Reports.
- 6
Liu H, Liu H, Liu C et al. (2022). Liu et al. 2022 — Gut Microbiome and the Role of Metabolites in the Study of Graves' Disease. Frontiers in Molecular Biosciences.
- 7
Catia Almeida, J. Guilherme Goncalves-Nobre, Diogo Alpuim Costa et al. (2023). The potential links between human gut microbiota and cardiovascular health and disease - is there a gut-cardiovascular axis?. Frontiers in Gastroenterology.
- 8
Sipos A, Ujlaki G, Miko E et al. (2021). The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Molecular Medicine.
- 9
Lori M. Poisson, Adnan Munkarah, Hala Madi et al. (2015). Poisson 2015 — A Metabolomic Approach to Identifying Platinum Resistance in Ovarian Cancer. Journal of Ovarian Research.
- 10
Hiroshi Nishiwaki, Jun Ueyama, Mikako Ito et al. (2024). Nishiwaki 2024 — Meta-analysis of shotgun sequencing of gut microbiota in Parkinson's disease (6 countries, riboflavin/biotin pathway depletion). npj Parkinson's Disease.
Article network
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
Add reviewed neuroinflammation coverage batch
Karen Pendergrass · +1 −1
Inspect exact Git diff ↗ - published revision
Consolidate microbial metabolite knowledge
Karen Pendergrass · +2 −2
Inspect exact Git diff ↗ - published revision
Backfill gut microbiome concept links
Karen Pendergrass · +1 −1
Inspect exact Git diff ↗ - published revision
Complete corpus-wide Dysbiosis linking
Karen Pendergrass · +1 −1
Inspect exact Git diff ↗ - published revision
massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers
WikiBiome Deploy Bot · +26 −20
Inspect exact Git diff ↗ - published revision
nightly maintenance: 94 stub demotions, 181 source_count fixes, 22 auto-discovered stubs, 5 adversarial audits, 3 boundary fixes, 3 evidence-level corrections
WikiBiome Deploy Bot · +2 −0
Inspect exact Git diff ↗ - published revision
pre-overnight checkpoint 2026-04-18
WikiBiome Deploy Bot · +91 −0
Inspect exact Git diff ↗

